CRMD CorMedix Inc.: institutional ownership and insider trading

209 funds reported holding $418M of CorMedix Inc. in their latest 13F filings; in Q2 2026 funds net bought $9.56M, with 24 new positions and 22 funds selling out; over the last 12 months insiders bought $0 and sold $2.64M on the open market; over its last four quarters it reported revenue of $462M and net income of $187M.

CRMD revenue and earnings

Famous investors holding CRMD

Largest institutional holders of CRMD

  1. VANGUARD GROUP INC — $52.3M
  2. BlackRock, Inc. (BLK) — $49.6M
  3. Deep Track Capital, LP — $49.3M
  4. VANGUARD CAPITAL MANAGEMENT LLC — $24.6M
  5. STATE STREET CORP (STT, STT-PG) — $18.2M
  6. ROYCE & ASSOCIATES LP — $17.1M
  7. GEODE CAPITAL MANAGEMENT, LLC — $15.3M
  8. UBS Group AG (UBS) — $14.7M
  9. SUSQUEHANNA INTERNATIONAL GROUP, LLP — $10.6M
  10. OBERWEIS ASSET MANAGEMENT INC/ — $10.4M

Recent CRMD insider trades

5%+ owners

Who owns the most CRMD stock?

The largest institutional holders of CorMedix Inc. in the latest 13F filings are VANGUARD GROUP INC ($52.3M), BlackRock, Inc. (BLK) ($49.6M), Deep Track Capital, LP ($49.3M).

Are insiders buying or selling CRMD?

Over the last 12 months insiders bought $0 and sold $2.64M of CorMedix Inc. stock on the open market (SEC Form 4).

Which famous investors own CRMD?

Ken Griffin, D. E. Shaw, Two Sigma.

What was CRMD's revenue last quarter?

CorMedix Inc. reported revenue of $102M for the quarter ended June 30, 2026, with net income of $26.0M.

Which ETFs hold CRMD?

10 ETFs and mutual funds hold it among their top 100 positions, including OBMCX, XPH, RCPFX, AUERX.

All CRMD 13F holders · All CRMD insider trades